Alleged Failure to Disclose Drug Safety Issues
Cornerstone Research was retained by a pharmaceutical company facing securities litigation after it withdrew a drug from the market because of safety concerns.
Tronox Holdings plc.’s Proposed Acquisition of TiZir Titanium and Iron
The FTC voted to close its investigation after the parties abandoned the transaction.
In the Matter of Methodist Le Bonheur Healthcare
Following the FTC’s lawsuit, the parties abandoned the proposed merger of two health systems.
ICC Arbitration Involving Commercially Reasonable Efforts to Develop and Commercialize a Drug
An ICC arbitration tribunal determined that the claimant did not materially breach its license agreement with the respondent, leaving the agreement in full effect.
California Public Utilities Commission Proceeding
Cornerstone Research consulted on competition in and regulation of the telecommunications market in California.
Nemet et al. v. Volkswagen Group of America Inc. et al.
A federal judge dismissed a proposed class action against Volkswagen and excluded plaintiffs’ expert evidence.
Students for Fair Admissions Inc. v. President and Fellows of Harvard College et al.
The U.S. District Court judge ruled in favor of Harvard on all counts.
Pro Bono: LCCRSF Report on the Role of Race in Non-Traffic Citations
Cornerstone Research provided pro bono analytical support for the LCCRSF’s report on racial disparities in non-traffic infractions.
FTC v. Qualcomm
The appellate court unanimously ruled in favor of Qualcomm, citing reasons that closely followed the expert’s testimony.
U.S.–Canada Softwood Lumber Dispute
The WTO and NAFTA issued favorable rulings for the Government of Canada in this decades-long case involving timber pricing and ownership.
U.S.A.–Canada Softwood Lumber Dispute
Cornerstone Research worked with an expert who analyzed the potential impact of eliminating export restrictions on softwood lumber.
Vignola v. FAT Brands Inc. et al.
The judge denied class certification in this securities class action alleging omissions in the prospectus of a Regulation A+ IPO.
How can we help you?
If you are looking for additional case experience examples, contact us.